Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

NCT01079793 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Overlapping study, PI preferred to enroll in alternate trial.

Conditions

Prostate Cancer

Interventions

DRUG: ixabepilone
PROCEDURE: adjuvant therapy
RADIATION: intensity-modulated radiation therapy

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]